Concordis Group Incorporated (CNGI) Stock
Concordis Group Incorporated (CNGI) functions as a diversified holding company, primarily focused on acquiring and overseeing a portfolio of various businesses and assets. Through its network of subsidiaries, the company maintains significant interests in a range of sectors, including financial services (investment banking), industrial manufacturing, energy projects, healthcare infrastructure (medical facilities), and real estate ventures.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Concordis Group Incorporated
Concordis Group Incorporated (CNGI) functions as a diversified holding company, primarily focused on acquiring and overseeing a portfolio of various businesses and assets. Through its network of subsidiaries, the company maintains significant interests in a range of sectors, including financial services (investment banking), industrial manufacturing, energy projects, healthcare infrastructure (medical facilities), and real estate ventures. Its service offerings include comprehensive real estate development capabilities, encompassing design, architectural planning, engineering, site preparation, and construction for both residential properties (like apartments and custom homes) and extensive, mixed-use commercial developments. Furthermore, Concordis provides specialized management and advisory services for investment banking, real estate, and oil and gas initiatives. The firm also operates dedicated investment funds, catering to institutional and high-net-worth investors who seek strategic and high-potential real estate acquisition opportunities. Concordis Group Incorporated was established in 2008 and has its headquarters situated in Dallas, Texas.
Concordis Group Incorporated is headquartered in US.
Concordis Group Incorporated (CNGI) stock trades at $0.12 with a market capitalization of $3.43M. The stock is valued at a price-to-earnings (P/E) ratio of 1.39, price-to-book of 0.90, price-to-sales of 0.51. Over the past 52 weeks the stock has ranged between $0.05 and $0.12, and currently trades at its 52-week high.
On profitability, Concordis Group Incorporated generates a return on equity (ROE) of 52.53% — well above the market average, a sign of a high-quality business, return on capital employed of 86.39%, an operating margin of 49.33%, a net profit margin of 36.97%.
Official website: www.concordisgrp.com